Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Pilot Study for SAPPORO-AF

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF. The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 120
Healthy Volunteers: f
View:

• Male or female patients age 40 years of age or older

• Patients with no history of atrial arrhythmia (atrial fibrillation, atrial flutter, atrial tachycardia) scheduled to undergo cardiac surgery (These surgeries include but are not limited to coronary artery bypass graft (CABG), valvular repair/reconstruction, aneurysm repair, and insertion of pacemaker).

Locations
United States
Louisiana
Tulane University Medical Center
RECRUITING
New Orleans
University Medical Center New Orleans
RECRUITING
New Orleans
Missouri
Washington University Barnes-Jewish Hospital
RECRUITING
St Louis
Contact Information
Primary
Quintrele Jones, MPH
qjones1@tulane.edu
504-988-3063
Backup
Chris Wang, MS
hwang37@tulane.edu
504-988-3065
Time Frame
Start Date: 2021-11-21
Estimated Completion Date: 2026-08
Participants
Target number of participants: 50
Sponsors
Leads: Tulane University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials